Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsLow false-negative rate of PCR analysis for detecting human papillomavirus-related cervical lesions.Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer.Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.Human papillomaviruses and cervical screening.Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated.The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity.Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia.Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytologyComparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion.A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings.Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3.Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma?Evaluation of immunoassays for the detection and typing of PCR amplified human papillomavirus DNA.HPV testing in patients with low grade cervical cytological abnormalities: a follow up study.Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology.Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3.Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ.Human papillomaviruses (HPV) in gynaecological cytology: from molecular biology to clinical testing.Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology.Squamous cell carcinoma of the penis in a man with a human papilloma virus 31 infection.Cytologic screening and human papilloma virus test in women undergoing artificial fertilization.Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.Elevated amount of human papillomavirus 31 DNA in a squamous cell carcinoma developed from bowenoid papulosis.Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples.HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ
P2860
Q24198236-E7E8B8B7-C23F-4B86-B66B-F430606EA5FEQ33683399-5575548E-EBBC-4506-8E7C-CFC76A4F9C9EQ33833645-46113BE9-2CD3-43A0-8204-5567EF2D56D9Q33887322-33BBDAA1-D136-40C8-B88B-965CAB360FA6Q33936103-F6A60AD8-F5F9-46E2-BE86-2C13AA728822Q35026841-6D55F61B-4361-43E9-8B06-F46B267736B7Q35209576-C433B703-F139-4D4E-992C-A8F3F01CAE86Q35977965-B564B529-4FA0-4C7D-B226-54E830581916Q36079862-053F7902-0D17-4143-BDF8-FC2B617438B0Q36544673-5613DCB0-2FB5-494F-B3E7-802356C5AB83Q36585245-B8E39317-1C45-4BD6-93CF-1BE5F01142EEQ36641198-75156654-8DAD-4371-A7E4-422EA8B1FDF2Q36670748-567B0062-B273-498E-BCCF-957528C230DFQ37177607-A1B8D46F-5C72-4F48-8F9C-7A90724AE02EQ37217783-8C0FB68C-803D-47B3-8612-6F3B20EA479FQ37218413-070C4C83-C977-4DF3-9ABC-04A1BE29B8ADQ37254122-A82FAFD0-0CFD-4960-933B-4E7A8E906010Q37300039-8261D14B-7C40-4361-BFDD-E7C98DD8D824Q37443985-D903CBE2-6062-4987-A3F7-C053BF6F64F4Q38445950-59F79CFC-DE09-43B7-8A27-26B0370C6387Q40479366-AECD269F-AC05-4F52-8ABE-AF8702062C40Q43566239-46C676DC-F5AF-4810-8BFF-8A7C1ABBEE2AQ44846813-A49951FF-366F-4B26-84F0-0B73B74DD199Q45730564-A9870EAC-2BC3-4B2F-8CD6-746F69ECE990Q47779516-A6CEE134-87CC-404D-93CB-B7A2BCBB0D5BQ53363361-4A0A83AC-BED7-4BDF-B808-3F2E2B3E1144Q54729502-99AE2777-936C-4AE9-8A80-E0335C5F01BDQ56998434-C9431D36-F3B0-41A3-B605-FBEA97372FFC
P2860
Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Use of semi-quantitative PCR f ...... ldly dyskaryotic smear report.
@ast
Use of semi-quantitative PCR f ...... ldly dyskaryotic smear report.
@en
type
label
Use of semi-quantitative PCR f ...... ldly dyskaryotic smear report.
@ast
Use of semi-quantitative PCR f ...... ldly dyskaryotic smear report.
@en
prefLabel
Use of semi-quantitative PCR f ...... ldly dyskaryotic smear report.
@ast
Use of semi-quantitative PCR f ...... ldly dyskaryotic smear report.
@en
P2093
P2860
P356
P1476
Use of semi-quantitative PCR f ...... ildly dyskaryotic smear report
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.110
P407
P577
1993-03-01T00:00:00Z